Oncolytics BiotechONCY
13F holders, Q3 2024 (September 30)42holders +1
7new positions
6sold out
1famous investor
$0.88avg. 13F price*
At the end of Q3 2024, 42 institutions reported holding Oncolytics Biotech Inc. (ONCY) in their 13F filings, up 1 from Q2 2024. 7 opened new positions and 6 sold out. The largest holders were International Assets Investment Management, LLC ($174K), Seeds Investor LLC ($165K) and Goldman Sachs Group Inc. ($74K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Oncolytics Biotech Inc.
- CUSIP
- 682310875
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $93K |
| Exits | 6 | $52K |
All 13F filers, Q2 2024 → Q3 2024: 145,431 shares bought and 232,968 shares sold, net −87,537 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 42 holders
| International Assets Investment Management, LLC | 0.01% | Add +0.9% | 200,150 | $174K |
| Seeds Investor LLC | 0.06% | No change | 189,941 | $165K |
| Goldman Sachs Group Inc. | 0.00% | Add +1.7% | 84,998 | $74K |
| Citadel Advisors | 0.00% | Reduce -42.2% | 79,249 | $69K |
| Royal Bank of Canada | 0.00% | Add +19.7% | 74,546 | $65K |
| Commonwealth Equity Services, LLC | 0.00% | Reduce -3.2% | 61,114 | $53K |
| Cibc World Market Inc. | 0.00% | No change | 57,835 | $51K |
| Geode Capital Management, LLC | 0.00% | No change | 41,942 | $37K |
| Long Focus Capital Management, LLC | 0.00% | No change | 40,000 | $35K |
| Bank of Montreal | 0.00% | Add +1.3% | 37,924 | $34K |
| Newman Dignan & Sheerar, Inc. | 0.01% | New | 22,015 | $27K |
| Morgan Stanley | 0.00% | Reduce -80.8% | 26,542 | $23K |
| SeaCrest Wealth Management, LLC | 0.00% | New | 26,000 | $23K |
| Brave Asset Management Inc. | 0.01% | No change | 25,000 | $22K |
| UBS Group AG | 0.00% | Add +309.4% | 22,936 | $20K |
| National Bank of Canada | 0.00% | Reduce -0.8% | 21,524 | $19K |
| Rovin Capital /Ut/ | 0.01% | New | 20,620 | $18K |
| LPL Financial LLC | 0.00% | Add +0.1% | 20,522 | $18K |
| Headinvest, LLC | 0.00% | No change | 17,434 | $15K |
| Federation des caisses Desjardins du Quebec | 0.00% | Add +18.8% | 15,796 | $14K |
| C2P Capital Advisory Group, LLC d.b.a. Prosperity Capital Advisors | 0.00% | No change | 15,000 | $13K |
| Two Sigma Securities, LLC | 0.00% | New | 14,079 | $12K |
| Ausdal Financial Partners, Inc. | 0.00% | Reduce -33.3% | 14,000 | $12K |
| BNP Paribas Financial Markets | 0.00% | Add +621.6% | 13,711 | $12K |
| Kingsview Wealth Management, LLC | 0.00% | No change | 11,000 | $10K |
| PFG Investments, LLC | 0.00% | No change | 10,500 | $9K |
| Professional Advisory Services Inc. | 0.00% | No change | 10,000 | $9K |
| Creative Planning | 0.00% | New | 10,330 | $9K |
| Osaic Holdings, Inc. | 0.00% | No change | 8,497 | $7K |
| Cedar Mountain Advisors, LLC | 0.00% | No change | 5,651 | $5K |
| Activest Wealth Management | 0.00% | No change | 5,000 | $4K |
| Wells Fargo & Company | 0.00% | No change | 4,401 | $4K |
| Principal Securities, Inc. | 0.00% | New | 3,000 | $3K |
| IFP Advisors, Inc | 0.00% | No change | 2,500 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -37.7% | 2,017 | $2K |
| Allworth Financial LP | 0.00% | No change | 2,000 | $2K |
| Bank of America Corp. | 0.00% | New | 1,800 | $2K |
| Cwm, LLC | 0.00% | No change | 1,325 | $1K |
| TD Waterhouse Canada Inc. | 0.00% | Reduce -15.9% | 557 | $481 |
| JNBA Financial Advisors | 0.00% | No change | 210 | $183 |
| Aviso Financial Inc. | 0.00% | Reduce -7.1% | 52 | $46 |
| Wolff Wiese Magana LLC | 0.00% | No change | 31 | $27 |
"% of holder's portfolio" is ONCY's weight in each manager's 13F, not the share of Oncolytics Biotech Inc. the manager owns.